Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 6, 2010 - Issue
Submit an article Journal homepage
104
Views
15
CrossRef citations to date
0
Altmetric
Review

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

Michael Pazianas1 The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, Nuffield Orthopaedic Centre, Headington, Oxford, UKCorrespondence[email protected] [email protected]
,
Cyrus Cooper1 The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, Nuffield Orthopaedic Centre, Headington, Oxford, UK;2 MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, Southampton, UK
,
F Hal Ebetino3 Warner Chilcott, New Jersey, USA
&
R Graham G Russell1 The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, Nuffield Orthopaedic Centre, Headington, Oxford, UK;4 The Mellanby Centre for Bone Research, Department of Human Metabolism, Sheffield University Medical School, Sheffield, UKCorrespondence[email protected] [email protected]
Pages 325-343 | Published online: 19 Jul 2010

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Omer Gendelman, Liana Tripto - Shkolnik, Iris Vered & Merav Lidar. (2022) Bisphosphonates Related Ocular Side Effects: A Case Series and Review of Literature. Ocular Immunology and Inflammation 30:7-8, pages 1995-1999.
Read now
Barry S Komm, Diana Morgenstern, Luis A Yamamoto & Simon N Jenkins. (2015) The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women. Expert Review of Clinical Pharmacology 8:6, pages 769-784.
Read now
E. Boschitsch. (2015) For how long should osteoporosis treatment continue?. Climacteric 18:5, pages 675-677.
Read now
Ankita Modi, Shiva Sajjan & Sampada Gandhi. (2014) Challenges in implementing and maintaining osteoporosis therapy. International Journal of Women's Health 6, pages 759-769.
Read now
Michael Pazianas, Bo Abrahamsen, Serge Ferrari & R Graham G Russell. (2013) Eliminating the need for fasting with oral administration of bisphosphonates. Therapeutics and Clinical Risk Management 9, pages 395-402.
Read now
Andrew J Yee & Noopur S Raje. (2012) Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients. Clinical Interventions in Aging 7, pages 331-338.
Read now
C. Cooper, J.-Y. Reginster, B. Cortet, M. Diaz-Curiel, R.S. Lorenc, J.A. Kanis & R. Rizzoli. (2012) Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Current Medical Research and Opinion 28:3, pages 475-491.
Read now
Mary K. Beard. (2012) Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference. Current Medical Research and Opinion 28:1, pages 141-147.
Read now
Jun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, Tsuyoshi Takeda & Hideo Matsumoto. (2011) Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture. Therapeutics and Clinical Risk Management 7, pages 257-264.
Read now
Michael Pazianas, Cyrus Cooper, Yiting Wang, Jeff L Lange & R Graham G Russell. (2011) Atrial fibrillation and the use of oral bisphosphonates. Therapeutics and Clinical Risk Management 7, pages 131-144.
Read now
Alex Fisher, Jodie Martin, Wichat Srikusalanukul & Michael Davis. (2010) Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary. Clinical Interventions in Aging 5, pages 355-362.
Read now

Articles from other publishers (4)

Daniel Halloran, Hilary W. Durbano & Anja Nohe. (2020) Bone Morphogenetic Protein-2 in Development and Bone Homeostasis. Journal of Developmental Biology 8:3, pages 19.
Crossref
Nursel DOĞANYİĞİT KUZAN & Esra Dilek KESKİN. (2020) OSTEOPOROZUN MEDİKAL TEDAVISINDE KULLANILAN İLAÇLAR VE YAN ETKİLERİ. Bozok Tıp Dergisi.
Crossref
Wei Gan, Robert J. Clarke, Anubha Mahajan, Benard Kulohoma, Hidetoshi Kitajima, Neil R. Robertson, N. William Rayner, Robin G. Walters, Michael V. Holmes, Zhengming Chen & Mark I. McCarthy. (2017) Bone mineral density and risk of type 2 diabetes and coronary heart disease: A Mendelian randomization study. Wellcome Open Research 2, pages 68.
Crossref
Ahmet Aslan, Ahmet Özmeriç, Ökkeş Bilal, Fatih Doğar, Zübeyde Özkaya & Emin Uysal. (2014) Comparative evaluation of clinical effectivity and side effects of two different parenteral agents used in the treatment of osteoporosis. Journal of Rheumatology and Orthopedics 1:1, pages 1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.